Mutations on PCSK1 lead to a misprocessing of melanocortin peptides, then leading to obesity and abnormalities of glucose homeostasis and adrenal function (O’Rahilly et al., 1995; Jackson et al., 1997). This evidence concerns the gene PCSK1 and obesity due to melanocortin 4 receptor deficiency.